Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer : an intergroup trial (E1193)
収録刊行物
-
- J Clin Oncol.
-
J Clin Oncol. 21 588-592, 2003